Literature DB >> 10758394

Vasorelaxant properties of nicorandil on human radial artery.

J R Sadaba1, K Mathew, C M Munsch, D J Beech.   

Abstract

OBJECTIVE: The radial artery is becoming popular as a conduit for coronary artery surgery but there is concern about its tendency to vasospasm. Diltiazem is used clinically in an effort to prevent vasospasm but there are suggestions that it is relatively ineffective. The first aim of the study was to test the effectiveness of Ca(2+) antagonists against vasospasm evoked by vasoconstrictor agonists. Because a large component of vasospasm was resistant to Ca(2+) antagonists, the second aim was to test if a different class of vasodilator, nicorandil, might relax the residual tone.
METHODS: Isometric tension was recorded in human radial artery segments harvested from patients undergoing myocardial revascularization surgery.
RESULTS: Diltiazem at 10 microM, which strongly inhibits L-type voltage-gated Ca(2+) channels, induced partial relaxation (mean+/-SEM, 44.6+/-3.5%, n=31) of phenylephrine-evoked contraction, but only 14.0+/-4.1% (n=10) and 12. 2+/-4.2% (n=10) relaxation of U46619- (a thromboxane A(2) analogue) or endothelin-1-evoked contraction. Strikingly, nicorandil relaxed agonist-evoked contractions that were resistant to diltiazem or nicardipine. In the absence of a Ca(2+) antagonist, nicorandil (30 microM) evoked 74.1+/-5.6% (n=24), 36.8+/-9.3% (n=10) and 64.5+/-7. 9% (n=14) relaxation of phenylephrine-, U46619- and endothelin-1-evoked contractions.
CONCLUSIONS: Nicorandil has a marked relaxant effect on contractions evoked by three different vasoconstrictor agonists, and relaxes vasospasm that is resistant to conventional Ca(2+) antagonists. These in vitro data suggest that nicorandil might be a useful drug for the inhibition of radial artery vasospasm in myocardial revascularization surgery.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10758394     DOI: 10.1016/s1010-7940(00)00325-0

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  2 in total

1.  Rho-kinase inhibitors prevent agonist-induced vasospasm in human internal mammary artery.

Authors:  T J Batchelor; J R Sadaba; A Ishola; P Pacaud; C M Munsch; D J Beech
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

2.  Acute simvastatin inhibits K ATP channels of porcine coronary artery myocytes.

Authors:  Sai Wang Seto; Alice Lai Shan Au; Christina Chui Wa Poon; Qian Zhang; Rachel Wai Sum Li; John Hok Keung Yeung; Siu Kai Kong; Sai Ming Ngai; Song Wan; Ho Pui Ho; Simon Ming Yuen Lee; Maggie Pui Man Hoi; Shun Wan Chan; George Pak Heng Leung; Yiu Wa Kwan
Journal:  PLoS One       Date:  2013-06-17       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.